Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label null responders. Show all posts
Showing posts with label null responders. Show all posts
Monday, October 1, 2012

Hepatitis C - Response to Interferon-α/Ribavirin Does Not Decrease on Retreatment

›
Response to Interferon-α/Ribavirin Does Not Decrease on Retreatment of Hepatitis C Among study participants with the same end-of-study res...
Friday, September 28, 2012

Protease Inhibitors - Maximizing Treatment Benefit in HCV

›
Alimentary Pharmacology & Therapeutics Despite Poor Interferon Response in Advanced Hepatitis C Virus Infection, Models of Protease In...
Monday, August 15, 2011

Dr.MLShiffman;Complexities of Treating Chronic Hepatitis C (HCV)

›
The Complexities of Treating Chronic Hepatitis C (HCV) “Dear Dr., I am a 57 year old female diagnosed with HCV 1B. In 2004, I got pneum...
Saturday, August 13, 2011

Realize the advance in Hepatitis C treatment, but remain cautious.

›
J Hepatol. 2011 Aug 8. [Epub ahead of print] Realize the advance in HCV treatment, but remain cautious. Asselah T . Source Service ...
Thursday, March 31, 2011

EASL;CTS-1027 Plus Pegasys/Riba geno 1 null-responder 24-week interim results in hepatitis C patients

›
Conatus Pharmaceuticals Presents Results From a Phase 2 Clinical Trial of CTS-1027 in HCV Genotype 1 Null-Responders By Conatus Pharmaceut...
Thursday, February 17, 2011

Hepatitis C-Phase 2 Trial CTS-1027 For Null Responder

›
Thursday, February 17, 2011 Look! Up In The Sky! It's Financings of the Fortnight! Excerpt From IN VIVO Conatus Pharmaceuticals: Liver d...
Thursday, January 13, 2011

Treating Hepatitis C With Telaprevir/SVR Stats 2011

›
My friends are back discussing SVR treating with Telaprevir in combination with Pegylated interferon and Ribavirin. . From more information ...
Thursday, December 9, 2010

IMO-2125 induces strong Th1-type (T helper type 1 cells) immune responses in null-responder Hepatitis C patients

›
Activation of the Innate Immune System: A Novel Immune Modulator for the Treatment of Hepatitis C Ekambar Kandimalla, PhD, VP of Discovery; ...
1 comment:
Friday, November 5, 2010

Hepatitis C: Why Do Nonresponders Not Respond

›
Ongoing Challenges in Hepatitis C: Why Do Nonresponders Not Respond Anne S. Henkel, MD; Steven L. Flamm, MD Authors and Disclosures CME Rele...